Synthesis and antimicrobial evaluation of novel lipophilic derivatives of pyrazolylisoxazolines

Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry

Volumn 52, Issue 2, 2013, Pages 259-265

  Chadha, Shally ^a   Khajuria, Rajni ^a   Paul, Satya ^a   Kapoor, Kamal K ^a  

^a UNIVERSITY OF JAMMU   (India)

Author keywords

Heterocycles; Isoxazoline 2; Lipophilic; Pyrazolylisoxazolines

Indexed keywords

EID: 84874852427     PISSN: 03764699     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Shailaja M, Manjula A, Vittal Rao B, Praseeda B & Reddy B M, Indian J Chem, 50B, 2011, 214.
2. Lee Y & Kim B H, Bioorg Med Chem Lett, 12, 2002, 1395.
3. Solankee A, Solankee S & Patel G, Rasayan J Chem, 1, 2008, 581.
4. Goel A & Madan AK, Stuctural Chemistry, 8, 1997, 155.
5. Madhavi K, Bharathi K & Prasad K V S R G, Res J Pharm Biol Chem Sci, 1, 2010, 1073.
6. Prasad R.Y., Rajasekhar K K, Shankarananth V, PradeepKumar G S S Reddy GH & Reddy BR, Pharm Res, 3, 2010, 2769.
7. Tirlapur V.K., Gandhi N, Basawaraj R & Prasad RY, Chem Tech Res, 2, 2010, 1434.
8. Millian D S, Prager R H, Brand C & Hart PH, Tetrahedron, 56, 2000, 811.
9. Revanasiddappa B.C., Rao R N, Subrahmanyam E V S & Satyanarayana D, E-Journal of Chemistry, 7, 2010, 295.
10. Palaska E, Aytemir M, Uzbay IT & Erol D, Eur J Med Chem, 36, 2001, 539.
11. Ozdemir Z, Kandilci H B, Gumusel B, Calis U & Bilgin AA, Arch Pharm Chem Life Sci, 341, 2008, 701.
12. Ramesh B & Sumana T, E-Journal of Chemistry, 7, 2010, 514.
13. Gowramma B, Jubie S, Kalirajan R., Gomathy S & Elango K, Pharm Tech Res, 1, 2009, 347.
14. Brzozowski Z, Kamiaski Z, Kozakiewicz I., Angielski S & Rogulski J, Acta Pol Pharm, 36, 1979, 401.
15. Bagheri M, Shekarchi M, Jorjani M., Ghahrenani M H, Vosooghi M & Shafiee A, Arch Pharm (Weinheim), 337, 2004, 25.
16. Sahu S.K., Banerjee M, Samantray A., Behera C & Azam MA, Pharm Res, 7, 2008, 961.
17. Kim Y.M., Farrah S & Baney RH, Int J Antimicrob Agents, 29, 2007, 217
18. (b) Lien E J, Hansch C & Anderson SM, J Med Chem, 11, 1968, 430
19. (c) Hunt W A, Adv Exp Med Biol, 56, 1975, 195.
20. Itoh K, Sakamaki H, Nakazato N., Horiuchi A, Horn E & Horiuchi AC, Synthesis, 20, 2005, 3541.
21. Naqvi T, Mahajan D, Sharma R L, Khan IA & Kapoor KK, J Heterocycl Chem, 48, 2011, 144.
22. Kapoor K.K., Ganai B A, Kumar S & Andotra CS, Synth Commun, 36, 2006, 2727.
23. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard. NCCLS Document M27-A2. National Committee for Clinical Laboratory Standards: PA Wayne, 2002.
24. National Committee for Clinical Laboratory Standards. Referance Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi: Approved Standard. NCCLS Document M-38-A. National Committee for Clinical Laboratory Standards: PA Wayne, 2002.
25. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacterial that Grow Aerobically: Approved Standard. NCCLS Document M7-A5. National Committee for Clinical Laboratory Standards: PA Wayne, 2000.